53 related articles for article (PubMed ID: 30529050)
21. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
Dayyani F; Uhlig S; Colson B; Simon K; Rolny V; Morgenstern D; Schlumbrecht M
Int J Gynecol Cancer; 2016 Nov; 26(9):1586-1593. PubMed ID: 27540691
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
[TBL] [Abstract][Full Text] [Related]
24. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511
[TBL] [Abstract][Full Text] [Related]
25. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers.
Carvalho VP; Grassi ML; Palma CS; Carrara HHA; Faça VM; Candido Dos Reis FJ; Poersch A
Transl Res; 2019 Apr; 206():71-90. PubMed ID: 30529050
[TBL] [Abstract][Full Text] [Related]
26. [Ovarian tumor markers of presumed benign ovarian tumors].
Lahlou N; Brun JL
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
[TBL] [Abstract][Full Text] [Related]
27. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.
Leung F; Diamandis EP; Kulasingam V
Biomark Med; 2012 Oct; 6(5):613-25. PubMed ID: 23075239
[TBL] [Abstract][Full Text] [Related]
28. Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract][Full Text] [Related]
29. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
30. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.
Capriglione S; Luvero D; Plotti F; Terranova C; Montera R; Scaletta G; Schirò T; Rossini G; Benedetti Panici P; Angioli R
Med Oncol; 2017 Aug; 34(9):164. PubMed ID: 28825178
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based proteomics techniques and their application in ovarian cancer research.
Swiatly A; Plewa S; Matysiak J; Kokot ZJ
J Ovarian Res; 2018 Oct; 11(1):88. PubMed ID: 30270814
[TBL] [Abstract][Full Text] [Related]
33. Current clinical application of serum biomarkers to detect ovarian cancer.
Nowak M; Janas Ł; Stachowiak G; Stetkiewicz T; Wilczyński JR
Prz Menopauzalny; 2015 Dec; 14(4):254-9. PubMed ID: 26848298
[TBL] [Abstract][Full Text] [Related]
34. The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects.
Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():229-44. PubMed ID: 26530369
[TBL] [Abstract][Full Text] [Related]
35. Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders.
Kappelmayer J; Antal-Szalmás P; Nagy B
Clin Chim Acta; 2015 Jan; 438():35-42. PubMed ID: 25127713
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
